Precision Biosciences Inc (DTIL) Technical Analysis
$6.50
Market is closed - opens 7 PM, 23 Mar 2026
Insights
- Precision Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Precision Biosciences stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Precision Biosciences stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Precision Biosciences stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 74.89 | Sell |
Stochastic | 75.69, 86.43 | Neutral |
Ultimate Oscillator | 62.16 | Neutral |
Stochastic Relative Strength Index | 89.49, 95.94 | Sell |
Moving Average Convergence Divergence | 0.68, 0.44 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.81 | Buy |
20 | 5.0 | Buy |
50 | 4.39 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.98 | Buy |
20 | 5.34 | Buy |
50 | 4.83 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 6.04 | Buy |
20 | 5.6 | Buy |
50 | 4.79 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 6.78 | Buy |
20 | 6.17 | Buy |
50 | 4.93 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 7.04 | Buy |
20 | 6.72 | Buy |
50 | 5.59 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 8.59 |
Resistance L2 | 8.09 |
Resistance L1 | 7.56 |
Pivot Point | 7.06 |
Support L1 | 6.53 |
Support L2 | 6.03 |
Support L3 | 5.5 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.